Healthcare Software integrates with QLAB ultrasound software.
Share:
Press Release Summary:
Integrating with QLAB ultrasound software from Philips Healthcare, Synapse(TM) ProSolv® cardiovascular v4.0.2 helps optimize clinical workflow and patient care, while minimizing potential for errors by automating exchange of data between systems. Program brings advanced quantification capabilities of QLAB, including 2D and 3D ultrasound, into echocardiographer's clinical practice. All exported images from QLAB are converted to DICOM format and stored with original study in ProSolv.
Original Press Release:
ProSolv Version 4.0.2 Makes Commercial Debut at ASE
First CVIS Integration with Philips QLAB ultrasound software now available
INDIANAPOLIS, May 26 /-- ProSolv CardioVascular, a Fujifilm company (ProSolv), is pleased to announce the commercial availability of Synapse(TM) ProSolv(R) cardiovascular version 4.0.2. Featuring the integration with QLAB advanced quantification software from Philips Healthcare, this latest software release from ProSolv has been designed to enhance clinical workflow, help improve patient care, and reduce the potential for errors by automating the exchange of data between the two systems. The product will be highlighted at the 20th Annual American Society of Echocardiography (ASE) Scientific Sessions to be held June 6-10, 2009, in Washington, DC.
"Our ability to be the first third party to deliver this advanced level of image and information integration with Philips' QLAB is further testament to ProSolv's commitment to our vendor-neutral strategy and to provide uniform clinical workflow throughout an echocardiography department regardless of the source of the information," stated Aaron Waitz, ProSolv President and CEO. "Efficiencies are gained by enabling customers to access proprietary ultrasound data and perform advanced strain rate and 3D analysis at the ProSolv workstation while utilizing the same clinical workflow currently used for routine image review, analysis and reporting with the Synapse ProSolv cardiovascular application," explained Waitz.
Synapse ProSolv cardiovascular version 4.0.2 provides workflow and diagnostic benefits by bringing ready access to the advanced quantification capabilities of QLAB -- including state-of-the-art 2D and 3D ultrasound -- into the echocardiographer's everyday clinical practice. With 4.0.2, users performing image review and reporting can launch the full QLAB application directly from the image in the Synapse ProSolv cardiovascular application for greater efficiency. And more importantly, all exported images from QLAB are converted to DICOM format and then stored with the original study in ProSolv. Clinicians can now review the entire study, including the processed 3D images, throughout the enterprise using ProSolv's Web capability, making this a powerful new combination of tools in the echocardiographer's toolkit.
For more information on Synapse ProSolv cardiovascular 4.0.2 or for a product demonstration, visit ProSolv CardioVascular at booth # 509 at ASE.
About ProSolv CardioVascular, a FUJIFILM Company
Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular's software solutions consist of advanced reporting and image management software, comprehensive support services and integration with third-party clinical applications. The Synapse(TM) ProSolv(R) cardiovascular Enterprise Image and Information Management solution improves physician productivity, enhances customer revenue opportunities, automates complex medical imaging workflow, and maximizes customers' return on investment in capital equipment and clinical information systems. The company is headquartered in Indianapolis, Indiana. For more information visit the ProSolv CardioVascular website at prosolv.com.
(C) 2009 ProSolv CardioVascular, a FUJIFILM Company
CONTACT: Katie Reynolds of ProSolv CardioVascular, +1-203-602-3670, katie.reynolds@fujimed.com
Web Site: http://prosolv.com/
